Antisense therapy is a form of treatment that uses antisense oligonucleotides (ASOs) to target messenger RNA (mRNA). ASOs are capable of altering mRNA...
23 KB (2,219 words) - 02:24, 20 August 2024
Sense (molecular biology) (redirect from Antisense)
various cell types. Some alternative antisense structural types have been experimentally applied as antisense therapy. In the United States, the Food and...
19 KB (2,444 words) - 17:30, 3 December 2023
Oligonucleotide (redirect from Oligonucleotides, antisense)
properties to the oligonucleotides and make them a key element in antisense therapy. Oligonucleotides are chemically synthesized using building blocks...
23 KB (2,581 words) - 08:14, 10 June 2024
Cystic fibrosis (redirect from Gene therapy for cystic fibrosis)
function would provide an alternative to traditional antibiotic therapies. Antisense therapy is being researched to treat a subset of mutations which have...
161 KB (18,151 words) - 09:04, 27 September 2024
Antisense RNA (asRNA), also referred to as antisense transcript, natural antisense transcript (NAT) or antisense oligonucleotide, is a single stranded...
24 KB (2,997 words) - 00:53, 25 July 2024
Pelacarsen (category Antisense RNA)
Pelacarsen is an antisense therapy that is designed to reduce Lipoprotein(a) concentrations in people with high levels of the lipoprotein and who are...
2 KB (196 words) - 18:00, 11 August 2024
Ionis Pharmaceuticals (category Antisense RNA)
of research of GlaxoSmithKline, with the goal of commercializing antisense therapy. In 1992, the company received its first approval by the Food and...
16 KB (1,428 words) - 12:29, 20 September 2024
RNA interference (redirect from RNAi therapy)
known as precise, efficient, stable and better than antisense therapy for gene suppression. Antisense RNA produced intracellularly by an expression vector...
141 KB (15,474 words) - 08:09, 11 August 2024
procedural practices. The modified gene therapy strategy of antisense IGF-I RNA (NIH n˚ 1602) using antisense / triple helix anti-IGF-I approach was registered...
176 KB (18,162 words) - 23:14, 25 September 2024
Olpasiran (category Antisense RNA)
Olpasiran (AMG890) is an experimental antisense therapy designed to lower the level of lipoprotein(a), which is believed to be a causal factor in the...
2 KB (183 words) - 01:20, 17 January 2024